rs5746849

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000754.4(COMT):​c.-91-5725A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.503 in 152,182 control chromosomes in the GnomAD database, including 19,551 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 19551 hom., cov: 34)

Consequence

COMT
NM_000754.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.674

Publications

9 publications found
Variant links:
Genes affected
COMT (HGNC:2228): (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]
COMT Gene-Disease associations (from GenCC):
  • paroxysmal dyskinesia
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000754.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.528 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000754.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COMT
NM_000754.4
MANE Select
c.-91-5725A>G
intron
N/ANP_000745.1P21964-1
COMT
NM_001135161.2
c.-92+4422A>G
intron
N/ANP_001128633.1P21964-1
COMT
NM_001135162.2
c.-92+3820A>G
intron
N/ANP_001128634.1P21964-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COMT
ENST00000361682.11
TSL:1 MANE Select
c.-91-5725A>G
intron
N/AENSP00000354511.6P21964-1
COMT
ENST00000406520.7
TSL:1
c.-92+3820A>G
intron
N/AENSP00000385150.3P21964-1
COMT
ENST00000964897.1
c.-91-5725A>G
intron
N/AENSP00000634956.1

Frequencies

GnomAD3 genomes
AF:
0.503
AC:
76442
AN:
152064
Hom.:
19531
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.534
Gnomad AMI
AF:
0.537
Gnomad AMR
AF:
0.468
Gnomad ASJ
AF:
0.656
Gnomad EAS
AF:
0.401
Gnomad SAS
AF:
0.512
Gnomad FIN
AF:
0.360
Gnomad MID
AF:
0.582
Gnomad NFE
AF:
0.511
Gnomad OTH
AF:
0.550
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.503
AC:
76505
AN:
152182
Hom.:
19551
Cov.:
34
AF XY:
0.496
AC XY:
36930
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.534
AC:
22163
AN:
41524
American (AMR)
AF:
0.468
AC:
7153
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.656
AC:
2276
AN:
3470
East Asian (EAS)
AF:
0.400
AC:
2066
AN:
5166
South Asian (SAS)
AF:
0.512
AC:
2470
AN:
4824
European-Finnish (FIN)
AF:
0.360
AC:
3807
AN:
10582
Middle Eastern (MID)
AF:
0.588
AC:
173
AN:
294
European-Non Finnish (NFE)
AF:
0.511
AC:
34746
AN:
67998
Other (OTH)
AF:
0.549
AC:
1162
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
2053
4106
6159
8212
10265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.504
Hom.:
27861
Bravo
AF:
0.509
Asia WGS
AF:
0.456
AC:
1587
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.88
DANN
Benign
0.26
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5746849;
hg19: chr22-19942997;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.